Kawamura K - Search Results

1

Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography.

Yamasaki T, Fujinaga M, Kawamura K, Hatori A, Yui J, Nengaki N, Ogawa M, Yoshida Y, Wakizaka H, Yanamoto K, Fukumura T, Zhang MR. Yamasaki T, et al. Among authors: kawamura k. Nucl Med Biol. 2011 Jul;38(5):707-14. doi: 10.1016/j.nucmedbio.2010.12.012. Epub 2011 Mar 3. Nucl Med Biol. 2011. PMID: 21718946

2

Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.

Kawamura K, Ishiwata K, Tajima H, Ishii S, Shimada Y, Matsuno K, Homma Y, Senda M. Kawamura K, et al. Nucl Med Biol. 1999 Nov;26(8):915-22. doi: 10.1016/s0969-8051(99)00069-4. Nucl Med Biol. 1999. PMID: 10708305

3

Preclinical evaluation of [11C]SA4503: radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain.

Kawamura K, Ishiwata K, Shimada Y, Kimura Y, Kobayashi T, Matsuno K, Homma Y, Senda M. Kawamura K, et al. Ann Nucl Med. 2000 Aug;14(4):285-92. doi: 10.1007/BF02988211. Ann Nucl Med. 2000. PMID: 11023029

4

[11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride.

Ishiwata K, Kobayashi T, Kawamura K, Matsuno K, Senda M. Ishiwata K, et al. Among authors: kawamura k. Nucl Med Biol. 2001 Oct;28(7):787-92. doi: 10.1016/s0969-8051(01)00238-4. Nucl Med Biol. 2001. PMID: 11578899

5

Synthesis and evaluation of (11)C-labeled (S)-N-[[1-(2-phenylethyl) pyrrolidin-2-yl]methyl]-3-methylthiobenzamide as a PET 5-HT(1A) receptor ligand.

Fujio M, Nagata S, Kawamura K, Sugiyama N, Tanaka H, Uno K, Ishiwata K. Fujio M, et al. Among authors: kawamura k. Nucl Med Biol. 2002 Aug;29(6):657-63. doi: 10.1016/s0969-8051(02)00305-0. Nucl Med Biol. 2002. PMID: 12234590

6

Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography.

Ishiwata K, Nariai T, Kimura Y, Oda K, Kawamura K, Ishii K, Senda M, Wakabayashi S, Shimada J. Ishiwata K, et al. Among authors: kawamura k. Ann Nucl Med. 2002 Sep;16(6):377-82. doi: 10.1007/BF02990074. Ann Nucl Med. 2002. PMID: 12416575

7

Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography.

Ogawa M, Hatano K, Kawasumi Y, Ishiwata K, Kawamura K, Ozaki S, Ito K. Ogawa M, et al. Among authors: kawamura k. Nucl Med Biol. 2003 Jan;30(1):51-9. doi: 10.1016/s0969-8051(02)00352-9. Nucl Med Biol. 2003. PMID: 12493543

8

Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies.

Kawamura K, Elsinga PH, Kobayashi T, Ishii S, Wang WF, Matsuno K, Vaalburg W, Ishiwata K. Kawamura K, et al. Nucl Med Biol. 2003 Apr;30(3):273-84. doi: 10.1016/s0969-8051(02)00439-0. Nucl Med Biol. 2003. PMID: 12745019

9

Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography.

Ishiwata K, Wang WF, Kimura Y, Kawamura K, Ishii K. Ishiwata K, et al. Among authors: kawamura k. Ann Nucl Med. 2003 May;17(3):205-11. doi: 10.1007/BF02990023. Ann Nucl Med. 2003. PMID: 12846542

10

Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study.

Ishiwata K, Kawamura K, Kimura Y, Oda K, Ishii K. Ishiwata K, et al. Among authors: kawamura k. Ann Nucl Med. 2003 Sep;17(6):457-62. doi: 10.1007/BF03006434. Ann Nucl Med. 2003. PMID: 14575379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,384 results

Search Page

Filters